½ÃÀ庸°í¼­
»óǰÄÚµå
1570759

¼¼°èÀÇ °æÀå ¿µ¾ç ½ÃÀå Á¶»ç º¸°í¼­ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2032³â)

Global Enteral Nutrition Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Value Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 283 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

°æÀå ¿µ¾ç ½ÃÀåÀÇ ¼¼°è ¼ö¿ä´Â 2023³â 48¾ï 1,000¸¸ ´Þ·¯¿¡¼­ 2032³â¿¡´Â ¾à 114¾ï 8,000¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ÃßÁ¤µÇ¸ç, Á¶»ç ±â°£ÀÎ 2024-2032³â CAGR·Î 10.15%ÀÇ ¼ºÀåÀÌ ¿¹ÃøµË´Ï´Ù.

°æÀå ¿µ¾çÀº Á¤¸Æ¿µ¾ç°ú ´Þ¸® Æ©ºê¸¦ ÅëÇØ ¼ÒÈ­°ü¿¡ Á÷Á¢ ¿µ¾çÀ» °ø±ÞÇÏ´Â ¹æ½ÄÀÔ´Ï´Ù. ÀÇ»ç´Â ÀÔÀ¸·Î À½½ÄÀ» ¸ÔÀ» ¼ö ¾øÁö¸¸ ¼ÒÈ­±â°üÀÌ ±â´ÉÇϴ ȯÀÚ¿¡°Ô ÀÌ ¹æ¹ýÀ» »ç¿ëÇÕ´Ï´Ù. »ïÅ´ Àå¾Ö, ¿µ¾ç Èí¼ö Àå¾Ö, ÁßÁõ Áúȯ µî ȯÀÚÀÇ ½Ä»ç ¿ä±¸¸¦ ÃæÁ·½Ã۱â À§ÇØ ¾×ü Á¦Á¦, ¿µ¾ç º¸ÃæÁ¦, Ư¼ö »ç·á µîÀÌ »ç¿ëµË´Ï´Ù. ÀÇ»ç´Â ȯÀÚÀÇ »óÅÂ¿Í ¿µ¾ç ¿ä±¸¿¡ µû¶ó ÄÚ, À§ ¶Ç´Â ¼ÒÀåÀÇ Æ©ºê¸¦ ÅëÇØ °æÀ念¾çÀ» ½ÃÇàÇÒ ¼ö ÀÖ½À´Ï´Ù. ÁÖ¿ä ¸ñÀûÀº ¿µ¾ç »óŸ¦ À¯ÁöÇϰųª °³¼±Çϰí ȸº¹°ú Ä¡À¯¸¦ µ½´Â °ÍÀÔ´Ï´Ù. ´õ ³ªÀº 󹿰ú Àü´Þ ½Ã½ºÅÛÀ¸·Î ÀÎÇØ °æÀå ¿µ¾çÁ¦´Â ´õ È¿°úÀûÀÌ°í »ç¿ëÇϱ⠽¬¿öÁ³À¸¸ç ¿À´Ã³¯ ÀÇ·áÀÇ Áß¿äÇÑ ºÎºÐÀÌ µÇ¾ú½À´Ï´Ù.

½ÃÀå ¿ªÇÐ

°æÀ念¾çÁ¦ ½ÃÀåÀº ¾Ï, ³ú Áúȯ, ÀåÁúȯ µî ½Ä»ç¿¡ ¾î·Á¿òÀ» °Þ´Â ¸¸¼ºÁúȯ ¹× ÁúȯÀÇ ±ÞÁõÀ¸·Î ÀÎÇØ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ¼¼°è Áúº´ ºÎ´ã ¿¬±¸(Global Burden of Disease Study)¿¡ µû¸£¸é ¾Ï°ú ³úÁ¹Áß°ú °°Àº ¸¸¼ºÁúȯÀÌ ´õ ÈçÇØÁö¸é¼­ °æÀ念¾çÁ¦¸¦ ÇÊ¿ä·Î ÇÏ´Â »ç¶÷µéÀÌ ´Ã¾î³¯ °ÍÀÔ´Ï´Ù. ¶ÇÇÑ °í·ÉÃþÀÌ ¿À·¡ »ì¸é¼­ ½Ä»ç ¼·Ãë¿Í ¼ÒÈ­¿¡ ¾î·Á¿òÀ» °Þ´Â °æ¿ì°¡ ¸¹±â ¶§¹®¿¡ °æ°ü ¿µ¾ç ¿É¼Ç¿¡ ´ëÇÑ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ±â¼ú Çõ½Åµµ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ÃÖ±Ù ¹ßÀü¿¡´Â ´õ ¸ÀÀÖ°í Æ¯Á¤ °Ç°­ ¹®Á¦¿¡ ´ëÇØ ´õ ±ÕÇü ÀâÈù Æ÷¹Ä·¯¸¦ ¸¸µå´Â °ÍÀÌ Æ÷ÇԵ˴ϴÙ. ¿¹¸¦ µé¾î Abbott¿Í Nestle Health Sciences´Â ¿µ¾ç Èí¼ö¸¦ µ½°í ȯÀÚÀÇ °Ç°­ »óŸ¦ °³¼±Çϴ Ư¼ö °æ°ü ¿µ¾ç Á¦Ç°À» Ãâ½ÃÇϰí ÀÖ½À´Ï´Ù. Àǻ簡 ȯÀÚ °³°³ÀÎÀÇ Çʿ信 ¸Â´Â ¿µ¾ç °ø±Þ °èȹÀ» ¼¼¿ï ¼ö ÀÖ´Â °³ÀÎ ¸ÂÃãÇü ¿µ¾ç ¿ä¹ýµµ ½ÃÀå ¼ºÀåÀÇ ±âȸ°¡ µÉ ¼ö ÀÖ½À´Ï´Ù. ÀÌ´Â ¿µ¾çÀ¯ÀüÇÐ ºÐ¾ßÀÇ »õ·Î¿î Çõ½ÅÀ» ÃËÁøÇÏ°í ´õ ¸¹Àº ¸ÂÃãÇü °æ°ü¿µ¾çÁ¦¸¦ ÀÌ¿ëÇÒ ¼ö ÀÖµµ·ÏÇÒ °ÍÀÔ´Ï´Ù.

Á¶»ç º¸°í¼­´Â Porter's Five Forces ¸ðµ¨, ½ÃÀå ¸Å·Âµµ ºÐ¼®, ¹ë·ùüÀÎ ºÐ¼®À» ´Ù·ç°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÅøÀº »ê¾÷ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇÏ°í ¼¼°è ¼öÁØ¿¡¼­ °æÀïÀÇ ¸Å·ÂÀ» Æò°¡ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ ÀÌ·¯ÇÑ ÅøÀº Àå³» ¿µ¾ç ¼¼°è ½ÃÀå¿¡¼­ °¢ ºÎ¹®À» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àå³» ¿µ¾çÁ¦ »ê¾÷ÀÇ ¼ºÀå°ú µ¿ÇâÀº ÀÌ Á¶»ç¿¡ ´ëÇÑ ÀüüÀûÀÎ Á¢±Ù ¹æ½ÄÀ» Á¦°øÇÕ´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­

°æÀå ¿µ¾ç ½ÃÀå º¸°í¼­ÀÇ ÀÌ ¼½¼Ç¿¡¼­´Â ±¹°¡ ¹× Áö¿ª ¼öÁØÀÇ ºÎ¹®¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ µ¥ÀÌÅ͸¦ Á¦°øÇÏ¿© Àü·«°¡°¡ ÇâÈÄ ±âȸ¸¦ ÅëÇØ °¢ Á¦Ç° ¹× ¼­ºñ½ºÀÇ ´ë»ó °í°´À» ½Äº°ÇÏ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.

Áö¿ª ºÐ¼®

ÀÌ ¼½¼Ç¿¡¼­´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ °æÀå ¿µ¾ç ½ÃÀåÀÇ ÇöÀç ¹× ¹Ì·¡ ¼ö¿ä¸¦ °­Á¶ÇÏ´Â Áö¿ª Àü¸ÁÀ» ´Ù·ì´Ï´Ù. ¶ÇÇÑ ¸ðµç ÁÖ¿ä Áö¿ªÀÇ °³º° ¿ëµµ¿¡ ´ëÇÑ ¼ö¿ä, ÃßÁ¤ ¹× ¿¹Ãø¿¡ ÃÊÁ¡À» ¸ÂÃß¾ú½À´Ï´Ù.

Ä¿½ºÅÒ ¿ä°ÇÀÌ ÀÖ´Â °æ¿ì, ¹®ÀÇÇØÁֽñ⠹ٶø´Ï´Ù. Value Market ResearchÀÇ Á¶»çÆÀÀÌ °í°´ÀÇ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇü ¸®Æ÷Æ®¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå °³¿ä

  • ½ÃÀåÀÇ ÇÏÀ̶óÀÌÆ®
  • ¼¼°è ½ÃÀå ½º³À¼ô

Á¦3Àå °æÀå ¿µ¾ç : »ê¾÷ ºÐ¼®

  • ¼­·Ð : ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ±âȸ
  • ¾÷°è µ¿Çâ
  • Porter's Five Forces ºÐ¼®
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

  • ¹ë·ùüÀÎ ºÐ¼®
  • ¿øÀç·á ºÐ¼®
    • ¿øÀç·á ¸®½ºÆ®
    • ¿øÀç·á Á¦Á¶¾÷ü ¸®½ºÆ®
    • ÁÖ¿ä ¿øÀç·áÀÇ °¡°Ý µ¿Çâ
  • ÀáÀçÀû ¹ÙÀÌ¾î ¸®½ºÆ®
  • ¸¶ÄÉÆÃ Ã¤³Î
    • ´ÙÀÌ·ºÆ® ¸¶ÄÉÆÃ
    • ÀδÙÀÌ·ºÆ® ¸¶ÄÉÆÃ
    • ¸¶ÄÉÆÃ Ã¤³Î ¹ßÀü µ¿Çâ

Á¦5Àå ¼¼°èÀÇ °æÀå ¿µ¾ç ½ÃÀå ºÐ¼® : ´Ü¹éÁú Á¶¼ºº°

  • °³¿ä : ´Ü¹éÁú Á¶¼ºº°
  • ½ÇÀû¡¤¿¹Ãø µ¥ÀÌÅÍ ºÐ¼® : ´Ü¹éÁú Á¶¼ºº°
  • Ç¥ÁØ ´Ü¹éÁú ´ÙÀÌ¾îÆ®
  • °í´Ü¹éÁú º¸ÃæÁ¦
  • ´ç´¢º´ ȯÀÚ¿ë ´Ü¹éÁú
  • ±âŸ

Á¦6Àå ¼¼°èÀÇ °æÀå ¿µ¾ç ½ÃÀå ºÐ¼® : Çüź°

  • °³¿ä : Çüź°
  • ½ÇÀû¡¤¿¹Ãø µ¥ÀÌÅÍ ºÐ¼® : Çüź°
  • ºÐ¸»
  • ¾×ü

Á¦7Àå ¼¼°èÀÇ °æÀå ¿µ¾ç ½ÃÀå ºÐ¼® : ¿¬·ÉÃþº°

  • °³¿ä : ¿¬·ÉÃþº°
  • ½ÇÀû¡¤¿¹Ãø µ¥ÀÌÅÍ ºÐ¼® : ¿¬·ÉÃþº°
  • ¼ºÀÎ(18¼¼ ÀÌ»ó)
  • ¼Ò¾Æ(18¼¼ ¹Ì¸¸)

Á¦8Àå ¼¼°èÀÇ °æÀå ¿µ¾ç ½ÃÀå ºÐ¼® : À¯Åë ä³Îº°

  • °³¿ä : À¯Åë ä³Îº°
  • ½ÇÀû¡¤¿¹Ãø µ¥ÀÌÅÍ ºÐ¼® : À¯Åë ä³Îº°
  • º´¿ø ÆÇ¸Å
  • ¼Ò¸Å
  • ¿Â¶óÀÎ

Á¦9Àå ¼¼°èÀÇ °æÀå ¿µ¾ç ½ÃÀå ºÐ¼® : Áö¿ªº°

  • Áö¿ªº° Àü¸Á
  • ¼­·Ð
  • ºÏ¹ÌÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ºÏ¹Ì : ºÎ¹®º°
    • ºÏ¹Ì : ±¹°¡º°
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´ÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • À¯·´ : ºÎ¹®º°
    • À¯·´ : ±¹°¡º°
    • ¿µ±¹
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ºÎ¹®º°
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ±¹°¡º°
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • µ¿³²¾Æ½Ã¾Æ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ¶óƾ¾Æ¸Þ¸®Ä« : ºÎ¹®º°
    • ¶óƾ¾Æ¸Þ¸®Ä« : ±¹°¡º°
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • Æä·ç
    • Ä¥·¹
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ºÎ¹®º°
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ±¹°¡º°
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • À̽º¶ó¿¤
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦10Àå °æÀå ¿µ¾ç ±â¾÷ÀÇ °æÀï ±¸µµ

  • °æÀå ¿µ¾ç ½ÃÀå °æÀï
  • Á¦ÈÞ/Çù·Â/ÇÕÀÇ
  • ÇÕº´°ú Àμö
  • ½ÅÁ¦Ç° ¹ß¸Å
  • ±âŸ °³¹ß

Á¦11Àå ±â¾÷ °³¿ä

  • »óÀ§ ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
  • ½ÃÀå ÁýÁßµµ
  • B. Braun Melsungen AG
  • Abbott Laboratories
  • Fresenius Kabi Ag
  • Danone S.A.
  • Hormel Foods Corporation
  • Global Health Products Inc.
  • Meiji Holdings Co. Ltd.
  • Reckitt Benckiser Group Plc.
  • Nestle S.A
  • Victus Inc
KSA 24.10.25

The global demand for Enteral Nutrition Market is presumed to reach the market size of nearly USD 11.48 Billion by 2032 from USD 4.81 Billion in 2023 with a CAGR of 10.15% under the study period 2024-2032.

Enteral nutrition involves feeding nutrients straight into the digestive tract through tubes, unlike intravenous methods. Doctors use this approach for patients who can't eat by mouth but have working digestive systems. It includes liquid formulas, nutritional supplements, and special feeds to meet the dietary needs of patients with conditions like trouble swallowing, poor nutrient absorption, or severe illnesses. Based on the patient's condition and nutritional needs, doctors can give enteral feeding through the nose, stomach, or small intestine tubes. The prime goal is to maintain or boost nutritional status and help recovery and healing. Better formulas and delivery systems have made this nutrition more effective and easy to use, making it a key part of today's medical care.

Market Dynamics

The enteral nutrition market is witnessing growth attributed to the propelling number of chronic diseases and conditions that make it hard to eat, like cancer, brain problems, and gut issues. As per the Global Burden of Disease Study, chronic diseases such as cancer and stroke will become more common, leading to more people needing tube feeding. Also, as more people live longer, there's a greater need for tube-feeding options since the older population often struggles to eat and digest food. Innovation is also propelling the market growth. Recent advancements include making formulas that taste better and are more balanced for specific health problems. For instance, Abbott and Nestle Health Science have introduced special tube feeding products that assist the body in absorbing nutrients better and improving how patients do. There are opportunities for market growth in personalized nutrition, which lets doctors create feeding plans that fit each patient's needs. This will drive new innovations in nutritional genetics and make more custom-made tube-feeding formulas available.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Enteral Nutrition. The growth and trends of Enteral Nutrition industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Enteral Nutrition market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Protein Composition

  • Standard Protein Diet
  • High Protein Supplement
  • Protein for Diabetes Care Patient
  • Others

By Form

  • Powder
  • Liquid

By Age Group

  • Adults (Above 18)
  • Pediatric (Below 18)

By Distribution Channel

  • Hospital Sales
  • Retail
  • Online

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Enteral Nutrition market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Enteral Nutrition market include B. Braun Melsungen AG, Abbott Laboratories, Fresenius Kabi Ag, Danone S.A., Hormel Foods Corporation, Global Health Products Inc., Meiji Holdings Co. Ltd., Reckitt Benckiser Group Plc., Nestle S.A, Victus Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. ENTERAL NUTRITION - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Protein Composition
    • 3.7.2 Market Attractiveness Analysis By Form
    • 3.7.3 Market Attractiveness Analysis By Age Group
    • 3.7.4 Market Attractiveness Analysis By Distribution Channel
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL ENTERAL NUTRITION MARKET ANALYSIS BY PROTEIN COMPOSITION

  • 5.1. Overview By Protein Composition
  • 5.2. Historical and Forecast Data Analysis By Protein Composition
  • 5.3. Standard Protein Diet Historic and Forecast Sales By Regions
  • 5.4. High Protein Supplement Historic and Forecast Sales By Regions
  • 5.5. Protein for Diabetes Care Patient Historic and Forecast Sales By Regions
  • 5.6. Others Historic and Forecast Sales By Regions

6. GLOBAL ENTERAL NUTRITION MARKET ANALYSIS BY FORM

  • 6.1. Overview By Form
  • 6.2. Historical and Forecast Data Analysis By Form
  • 6.3. Powder Historic and Forecast Sales By Regions
  • 6.4. Liquid Historic and Forecast Sales By Regions

7. GLOBAL ENTERAL NUTRITION MARKET ANALYSIS BY AGE GROUP

  • 7.1. Overview By Age Group
  • 7.2. Historical and Forecast Data Analysis By Age Group
  • 7.3. Adults (Above 18) Historic and Forecast Sales By Regions
  • 7.4. Pediatric (Below 18) Historic and Forecast Sales By Regions

8. GLOBAL ENTERAL NUTRITION MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 8.1. Overview By Distribution Channel
  • 8.2. Historical and Forecast Data Analysis By Distribution Channel
  • 8.3. Hospital Sales Historic and Forecast Sales By Regions
  • 8.4. Retail Historic and Forecast Sales By Regions
  • 8.5. Online Historic and Forecast Sales By Regions

9. GLOBAL ENTERAL NUTRITION MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE ENTERAL NUTRITION COMPANIES

  • 10.1. Enteral Nutrition Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF ENTERAL NUTRITION INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. B. Braun Melsungen AG
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Abbott Laboratories
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Fresenius Kabi Ag
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Danone S.A.
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Hormel Foods Corporation
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Global Health Products Inc.
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Meiji Holdings Co. Ltd.
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Reckitt Benckiser Group Plc.
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Nestle S.A
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Victus Inc
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦